KT

Koji Tamada

CY Cytlimic: 5 patents #1 of 6Top 20%
NC National Cancer Center: 1 patents #17 of 69Top 25%
YU Yamaguchi University: 1 patents #2 of 15Top 15%
📍 Ube, MD: #1 of 1 inventorsTop 100%
Overall (2020): #24,619 of 565,922Top 5%
6
Patents 2020

Issued Patents 2020

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10875900 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Keiko Udaka 2020-12-29
10842848 Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein Tomoya Miyakawa, Shun Doi 2020-11-24
10781249 Anti-GPC3 antibody Yukimi Sakoda, Tetsuya Nakatsura, Keigo Saito 2020-09-22
10590179 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Keiko Udaka 2020-03-17
10537626 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell Tomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Keiko Udaka 2020-01-21
10526388 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells Tomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Keiko Udaka 2020-01-07